Iovance Biotherapeutics (IOVA) Misses Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Iovance Biotherapeutics (IOVA) Halted on LUDP
February 25, 2020 1:18 PM ESTIovance Biotherapeutics (NASDAQ: IOVA) Halted on LUDP
... MoreUPDATE: Iovance Biotherapeutics (IOVA) Said to Explore Potential Sale - Bloomberg
February 25, 2020 1:17 PM EST(Updated - February 25, 2020 1:21 PM EST)
Iovance Biotherapeutics (NASDAQ: IOVA) is exploring a sale and held preliminary talks with potential buyers, according to Bloomberg, citing people familiar with the matter.
It is working with a financial adviser after receiving takeover interest.
... More